Clinical Value of Sampling Time of Metagenomic Next-Generation Sequencing in Patients with Severe Pneumonia
Shixiao Li,Peng Zhou,Lihong Yang,Tianbin Tang,Jiajia Qin,Jiao Qian,Shen Bo,Sufei Yu
DOI: https://doi.org/10.2147/IDR.S424185
2023-08-15
Infection and Drug Resistance
Abstract:Shixiao Li, 1 Peng Zhou, 2 Lihong Yang, 1 Tianbin Tang, 1 Jiajia Qin, 1 Jiao Qian, 1 Shen Bo, 1 Sufei Yu 1 1 Department of Clinical Microbiology Laboratory, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, Zhejiang, People's Republic of China; 2 Department of Pharmacy, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China Correspondence: Sufei Yu, Email Objective: Severe pneumonia is a common infectious disease with high morbidity and mortality. Early etiological diagnosis is crucial for improving the prognosis. The aim of this study is to evaluate the clinical value of sampling time of mNGS in patients with severe pneumonia. Methods: This retrospective study enrolled 105 patients with severe pneumonia. mNGS was performed on bronchoalveolar lavage fluid (BALF). Patients were divided into the sampling time ≤ 72h vs sampling time > 72h groups and survivors vs non-survivors groups according to their sampling time and prognosis. Clinical characteristics, the adjustment of antibiotics and clinical prognostic value were evaluated. Results: Our study showed that, early sampling of mNGS can significantly shorten the mechanical ventilation time ( p = 0.007) and hospitalization time ( p = 0.004). In the non-survivors group, CURB-65, SOFA, and APACHE II scores were higher. Age (OR: 1.051, 95% CI: 1.004– 1.100, p = 0.034), chronic respiratory diseases (OR: 4.639, 95% CI: 1.260– 17.082, p = 0.021), immunosuppression (OR: 5.008, 95% CI: 1.617– 15.510, p = 0.005) and SOFA score on the day of mNGS sampling (OR: 1.492, 95% CI: 1.212– 1.837, p 72h group, and the proportion of antifungal and antiviral agents adjusted was lower. In the early sampling group, it was significantly decreased in the CRP, PCT level and NEU% at discharge. Conclusion: This study demonstrated that early sampling of mNGS could shorten the time of mechanical ventilation and hospitalization of patients with severe pneumonia. Patients with higher SOFA score on the day of sampling had a poorer prognosis. It emphasizes that early sampling of mNGS has a positive value. Keywords: metagenomic next generation sequencing, severe pneumonia, sampling time, mortality Severe pneumonia is associated with high morbidity and mortality, especially in the ICU, and is one of the global burdens of infectious diseases. 1,2 For patients with severe pneumonia, rapid identification of pathogens and timely initiation of appropriate anti-infective therapy are the most critical determinants of prognosis. Furthermore, pathogen diagnosis is a key step in anti-infective treatment. Enteric Gram-negative bacilli, Staphylococcus aureus and non-fermentative bacteria accounted for most isolates from lower respiratory tract specimens. Atypical infections (2%) were uncommon. 3 Viruses, except the influenza virus, respiratory viruses accounted for approximately 13.5–56.2% of community-acquired pneumonia (CAP). 4 Conventional microbial culture methods, serological antigen and/or antibody testing and polymerase chain reaction (PCR) have limitations for pathogens detection, only using specific primers or probes, and only targeting a limited number of pathogens. As high-throughput and unbiased sequencing-based pathogens detection technology, mNGS characterizes all DNA or RNA existing in various clinical samples, providing new diagnostic evidence, which can be used to guide treatment planning and improve antibiotic management. 5–7 In this study, we performed microbial mNGS assays on respiratory tract specimens of patients with severe pneumonia. However, reports on evaluating the impact of mNGS sampling time on patients with severe pneumonia remain scarce. The purpose of this study was to evaluate the correlation between the different sampling time of mNGS with the prognosis of patients with severe pneumonia, and to evaluate the benefits of early detection, which may be helpful to make more accurate clinical decisions. Patients hospitalized for suspected pneumonia from January 2019 to November 2022 were recruited from Taizhou Hospital of Zhejiang Province. All patients met the American Thoracic Society/ the Infectious Disease Society of America (ATS/IDSA 2019) criteria for predicting severe pneumonia. 8 Inclusio -Abstract Truncated-
pharmacology & pharmacy,infectious diseases